Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Potential of Fermented Food-Derived <i>Lactiplantibacillus</i> Cell-Free Supernatants to Control <i>Staphylococcus aureus</i> Growth and Biofilm Development.

International journal of molecular sciencesĀ·2026
Same author

A Metagenomic Comparison of the Colostrum Microbiome in Bulgarian Mothers by Delivery Mode: A Pilot Study.

MicroorganismsĀ·2026
Same author

In Vitro Probiotic Modulation of Specific Dietary Complex Sugar Consumption in Fecal Cultures in Infants.

MicroorganismsĀ·2025
Same author

Unveiling the <i>Petunia hybrida</i> Virome: Metatranscriptomic Profiling from the Bulgarian Market and In Vitro Cultures.

Plants (Basel, Switzerland)Ā·2025
Same author

Bioinformatics Research in Bacterial Genomics and Metagenomics.

Current issues in molecular biologyĀ·2025
Same author

Correction: Proteomic profiling and functional analysis of extracellular vesicles from metastasis-competent circulating tumor cells in colon cancer.

Journal of experimental & clinical cancer research : CRĀ·2025
Same journal

RETRACTED: Sabir et al. DNA Based and Stimuli-Responsive Smart Nanocarrier for Diagnosis and Treatment of Cancer: Applications and Challenges. <i>Cancers</i> 2021, <i>13</i>, 3396.

CancersĀ·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

CancersĀ·2026
Same journal

Correction: PeƱalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

CancersĀ·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

CancersĀ·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

CancersĀ·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

CancersĀ·2026
See all related articles

Related Experiment Video

Updated: Jul 25, 2025

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.0K

Liquid Biopsy: Current Status and Future Perspectives.

Vesselin Baev1, Danijela Koppers-Lalic2, Bruno Costa-Silva3

  • 1Department of Plant Physiology and Molecular Biology, University of Plovdiv, 4000 Plovdiv, Bulgaria.

Cancers
|June 28, 2023
PubMed
Summary
This summary is machine-generated.

Biofluid analysis is crucial for cancer diagnosis and monitoring. Biomarker discovery in bodily fluids aids in understanding and managing oncological conditions effectively.

More Related Videos

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.1K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.9K

Related Experiment Videos

Last Updated: Jul 25, 2025

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.0K
Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients
08:25

Detection of Cell-Free DNA in Blood Plasma Samples of Cancer Patients

Published on: September 9, 2020

11.1K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.9K

Area of Science:

  • Oncology
  • Biochemistry
  • Medical Diagnostics

Background:

  • The historical analysis of biofluids for cancer detection dates back to the Bence Jones protein discovery in the 19th century.
  • Key protein biomarkers like carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) were identified in the 1970s, highlighting biofluid utility.
  • Modern advancements continue to leverage biofluid analysis for cancer management.

Discussion:

  • Biofluid analysis provides a minimally invasive approach to cancer detection and monitoring.
  • Biomarkers in biofluids offer insights into tumor presence, progression, and treatment response.
  • The evolution of analytical techniques enhances the sensitivity and specificity of cancer biomarker detection.

Key Insights:

  • The long-standing role of biofluid analysis in oncology underscores its diagnostic significance.
  • Identification of specific biomarkers like CEA and AFP revolutionized cancer follow-up.
  • Ongoing research focuses on novel biofluid biomarkers for earlier and more accurate cancer diagnosis.

Outlook:

  • Future directions include the development of multi-analyte panels for comprehensive cancer profiling.
  • Liquid biopsy technologies are poised to transform cancer diagnostics and personalized medicine.
  • The integration of artificial intelligence with biofluid analysis will accelerate biomarker discovery and clinical application.